5 March 2018
Authored and Edited by Hazel Ford, Ph.D.; Leythem A. Wall
Since 1 March 2018, it has been possible to obtain patent protection in 44 countries across Europe and beyond into north Africa and southeast Asia, by filing a single patent application in the European Patent Office (EPO).
In addition to the 38 countries that are member states of the European Patent Organisation, patent protection can be obtained in some additional countries by paying further official fees to the EPO at the same time as paying the EPO’s official designation fee, and then confirming the local registration of the patent in those countries after a patent has been granted by the EPO.
Between 1993 and 2009, the EPO entered into cooperation agreements with ten countries in the European region that were not EPO member states. Most of those countries have since become full member states, but it is still possible to use these agreements to obtain protection in Montenegro and in Bosnia & Herzegovina. These are referred to by the EPO as “extension states”.
More recently, the EPO has entered into agreements with countries that are further afield, known as “validation states”. In 2015 it became possible to validate a European patent in Morocco and in the Republic of Moldova. In December 2017, Tunisia was added as a further validation state and, most recently, a validation agreement with Cambodia came into effect on 1 March 2018. Under these agreements, it is possible to validate a European patent in these countries, where it will then confer essentially the same protection as a European patent would in one of the EPO’s member states.
It should be noted that it is not currently possible to use this EPO validation route to obtain patent protection in Cambodia for pharmaceutical products. This is because pharmaceutical products are excluded from patent protection in Cambodia, as permitted under the World Trade Organisation (WTO) waiver for Least Developed Countries. It is, however, still possible to file patent applications for pharmaceutical inventions in Cambodia: they will be put on hold until the waiver expires, currently expected to be in January 2033. At that stage, protection in Cambodia may be granted for the remainder of the patent term, calculated from the filing date of the application.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Conference
2024 Licensing Executives Society USA – Canada Annual Meeting
October 20-23, 2024
New Orleans
Conference
2024 Corporate Counsel Women of Color: Career Strategies Conference
October 2-5, 2024
Las Vegas
Hybrid Conference
2024 New York Intellectual Property Law Institute
September 30 - October 1, 2024
New York
Hybrid Conference
2024 Patent Law Institute: Critical Issues & Best Practices
September 30 - October 1, 2024
New York
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.